Literature DB >> 15952417

Hemolyzed plasma samples in diabetic ketoacidosis (DKA).

L Sojo, A M Wägner, J Ordóñez, R Corcoy.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15952417     DOI： 10.1007/bf03345389

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  8 in total

1.  Oxidative stress in families of type 1 diabetic patients.

Authors:  E Matteucci; O Giampietro
Journal:  Diabetes Care       Date:  2000-08       Impact factor: 19.112

2.  Energy metabolism and lipid peroxidation of human erythrocytes as a function of increased oxidative stress.

Authors:  B Tavazzi; D Di Pierro; A M Amorini; G Fazzina; M Tuttobene; B Giardina; G Lazzarino
Journal:  Eur J Biochem       Date:  2000-02

3.  Oxidative markers in diabetic ketoacidosis.

Authors:  M C Vantyghem; M Balduyck; F Zerimech; A Martin; C Douillard; S Bans; P M Degand; J Lefebvre
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

Review 4.  Induction of atherosclerosis by human chylomicron remnants: a hypothesis.

Authors:  Monica G Wilhelm; Allen D Cooper
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

5.  Simultaneous occurrence of hypercholesterolemia and hemolytic anemia in rats fed cholesterol diet.

Authors:  K Akahane; K Furuhama; T Onodera
Journal:  Life Sci       Date:  1986-08-11       Impact factor: 5.037

6.  Oxidative stress: an important phenomenon with pathogenetic significance in the progression of acute pancreatitis.

Authors:  K Tsai; S S Wang; T S Chen; C W Kong; F Y Chang; S D Lee; F J Lu
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

7.  Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus.

Authors:  M Kalousová; J Skrha; T Zima
Journal:  Physiol Res       Date:  2002       Impact factor: 1.881

8.  Suppression of oxidative stress as a mechanism of reduction of hypercholesterolemic atherosclerosis by aspirin.

Authors:  Kailash Prasad; Paul Lee
Journal:  J Cardiovasc Pharmacol Ther       Date:  2003-03       Impact factor: 2.457
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.